Risk of Suicidal Behaviors and Antidepressant Exposure Among Children and Adolescents: A Meta-Analysis of Observational Studies
- PMID: 35693956
- PMCID: PMC9178080
- DOI: 10.3389/fpsyt.2022.880496
Risk of Suicidal Behaviors and Antidepressant Exposure Among Children and Adolescents: A Meta-Analysis of Observational Studies
Abstract
Objectives: Although several studies have reviewed the suicidal risk of antidepressants, the conclusions remain inconsistent. We, therefore, performed a meta-analysis of observational studies to address the association between exposure to antidepressants, especially selective serotonin reuptake inhibitors (SSRIs) and the risk of suicide and suicide attempt in children and adolescents.
Methods: MEDLINE and Embase were searched from January 1990 to April 2021. Seventeen cohort and case-control studies were identified that reported suicide or suicide attempt in children and young adults (aged 5-25 years) who were exposed to any antidepressants. We extracted the estimates and corresponding 95% confidence intervals (CIs) from each publication.
Results: The results showed that antidepressant exposure significantly increased the risk of suicide and suicide attempt when compared with no antidepressant usage among children and adolescents. The pooled relative risk (RR) was 1.38 (95% CI: 1.16-1.64; I 2 = 83.1%). Among the antidepressants, SSRI use was associated with an increased risk of suicide and suicide attempt, and the pooled RR was 1.28 (95% CI: 1.09-1.51; I 2 = 68.8%). In subgroup analysis, the attempted suicidal risk of antidepressant and SSRI was significantly increased (RR = 1.35, 95% CI: 1.13-1.61; I 2 = 86.2% for all antidepressants; and RR = 1.26, 95% CI: 1.06-1.48; I 2 = 73.8% for SSRIs), while the completed suicidal risk of antidepressant and SSRI was not statistically significant (RR = 2.32, 95% CI: 0.82-6.53; I 2 = 6.28% for all antidepressants; and RR = 1.88, 95% CI: 0.74-4.79; I 2 = 52.0% for SSRIs). In addition, the risk of suicide and suicide attempt between SSRIs and other antidepressants was similar (RR 1.13, 95% CI: 0.87-1.46, I 2 = 32.4%).
Conclusion: The main findings of this meta-analysis provide some evidence that antidepressant exposure seems to have an increased suicidal risk among children and young adults. Since untreated depression remains one of the largest risk factors for suicide and the efficacy of antidepressants is proven, clinicians should evaluate carefully their patients and be cautious with patients at risk to have treatment emergence or worsening of suicidal ideation (TESI/TWOSI) when prescribing antidepressants to children and young patients.
Keywords: SSRIs; antidepressants; children and adolescents; suicide; suicide attempt.
Copyright © 2022 Li, Zhou, Xiao, Gu, Chen, Xie and Wu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.JAMA. 2007 Apr 18;297(15):1683-96. doi: 10.1001/jama.297.15.1683. JAMA. 2007. PMID: 17440145
-
Antidepressants and the risk of suicidal behaviors.JAMA. 2004 Jul 21;292(3):338-43. doi: 10.1001/jama.292.3.338. JAMA. 2004. PMID: 15265848
-
Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies.CMAJ. 2009 Feb 3;180(3):291-7. doi: 10.1503/cmaj.081514. CMAJ. 2009. PMID: 19188627 Free PMC article. Review.
-
Suicide-related events in young people following prescription of SSRIs and other antidepressants: a self-controlled case series analysis.BMJ Open. 2013 Sep 19;3(9):e003247. doi: 10.1136/bmjopen-2013-003247. BMJ Open. 2013. PMID: 24056479 Free PMC article.
-
[SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].Tijdschr Psychiatr. 2009;51(6):387-93. Tijdschr Psychiatr. 2009. PMID: 19517368 Review. Dutch.
Cited by
-
Major challenges in youth psychopathology: treatment-resistant depression. A narrative review.Front Psychiatry. 2024 Jul 11;15:1417977. doi: 10.3389/fpsyt.2024.1417977. eCollection 2024. Front Psychiatry. 2024. PMID: 39056019 Free PMC article. Review.
-
Diagnosis and management of depression in adolescents.CMAJ. 2023 May 29;195(21):E739-E746. doi: 10.1503/cmaj.220966. CMAJ. 2023. PMID: 37247881 Free PMC article. Review. No abstract available.
-
Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth.J Psychopharmacol. 2023 Aug;37(8):775-783. doi: 10.1177/02698811231171531. Epub 2023 May 16. J Psychopharmacol. 2023. PMID: 37194253 Free PMC article.
-
The Effect of Herbal Medicine on Suicidal Behavior: A Protocol for Systematic Review and Meta-Analysis.Healthcare (Basel). 2023 May 11;11(10):1387. doi: 10.3390/healthcare11101387. Healthcare (Basel). 2023. PMID: 37239673 Free PMC article.
-
Diagnostic et traitement de la dépression à l’adolescence.CMAJ. 2023 Aug 14;195(31):E1050-E1058. doi: 10.1503/cmaj.220966-f. CMAJ. 2023. PMID: 37580075 Free PMC article. Review. French. No abstract available.
References
-
- U.S. Food and Drug Administration. Suicidality in Children and Adolescents Being Treated with Antidepressant Medications. Silver Spring, MD: US FDA; (2004).
-
- FDA. Antidepressant Use in Children, Adolescents, and Adults. Silver Spring, MD: FDA; (2007).
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
